Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human (3) Apply Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Withdrawn applications Remove Withdrawn applications filter Paediatric investigation plans Remove Paediatric investigation plans filter Referrals Remove Referrals filter

Product number

Date of opinion

From:

To:

Decision date

From:

To:

Referral name

Referral status

European Commission final decision (2) Apply European Commission final decision filter Opinion provided by Committee for Medicinal Products for Human Use (1) Apply Opinion provided by Committee for Medicinal Products for Human Use filter

Referral safety status

Yes Remove Yes filter

Referral type

Article 20 procedures (3) Apply Article 20 procedures filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC Remove PRAC-CHMP-EC filter

Referral authorisation model

Centrally authorised product(s) Remove Centrally authorised product(s) filter Centrally and nationally authorised products (mixed) (3) Apply Centrally and nationally authorised products (mixed) filter

Referral PRAC recommendation

Risk minimisation measures (2) Apply Risk minimisation measures filter Suspension (1) Apply Suspension filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Medicine type

Accelerated assessment Remove Accelerated assessment filter Additional monitoring Remove Additional monitoring filter Exceptional circumstances Remove Exceptional circumstances filter Generic Remove Generic filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

3 results

Remove all filtersRemove all filters

Keyword Remove keyword

Medicine European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter Paediatric investigation plans Remove Paediatric investigation plans filter Withdrawn applications Remove Withdrawn applications filter

Medicine type Generic Remove Generic filter Exceptional circumstances Remove Exceptional circumstances filter Accelerated assessment Remove Accelerated assessment filter Additional monitoring Remove Additional monitoring filter

Referral decision making model PRAC-CHMP-EC Remove PRAC-CHMP-EC filter

Referral authorisation model Centrally authorised product(s) Remove Centrally authorised product(s) filter

Referral safety status Yes Remove Yes filter

Sort by

List item

Referral: Picato

ingenol mebutate, associated names: Picato, Article 20 procedures
Status: European Commission final decision, opinion/position date: 30/04/2020, EC decision date: 06/07/2020, Last updated: 16/11/2020
List item

Referral: Lemtrada

alemtuzumab, associated names: Lemtrada, Article 20 procedures
Status: European Commission final decision, opinion/position date: 14/11/2019, EC decision date: 16/01/2020, Last updated: 04/02/2020
List item

Referral: Janus kinase inhibitors (JAKi) (updated)

tofacitinib, abrocitinib, baricitinib, upadacitinib, filgotinib, associated names: Xeljanz, Cibinqo, Olumiant, Rinvoq, Jyseleca, Article 20 procedures
Status: Opinion provided by Committee for Medicinal Products for Human Use, opinion/position date: 12/01/2023, Last updated: 27/01/2023

3 results

Referral: Picato

Referral: Lemtrada

Referral: Janus kinase inhibitors (JAKi) (updated)